These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15913489)

  • 21. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of hypertension in atherosclerosis and cardiovascular disease.
    Hollander W
    Am J Cardiol; 1976 Nov; 38(6):786-800. PubMed ID: 136891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prothrombotic and antithrombotic pathways in acute coronary syndromes.
    Selwyn AP
    Am J Cardiol; 2003 Jun; 91(12A):3H-11H. PubMed ID: 12818729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
    J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension.
    Lip GY; Blann AD; Beevers DG
    J Hypertens; 1999 Aug; 17(8):1203-7. PubMed ID: 10466477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study.
    Catena C; Colussi G; Fedrizzi S; Sechi LA
    J Hypertens; 2013 Oct; 31(10):2077-84. PubMed ID: 24107736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congestive heart failure and Virchow's triad: a neglected association.
    Sosin MD; Bhatia G; Davis RC; Lip GY
    Wien Med Wochenschr; 2003; 153(19-20):411-6. PubMed ID: 14648920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
    Gerdts E; Wachtell K; Omvik P; Otterstad JE; Oikarinen L; Boman K; Dahlöf B; Devereux RB
    Hypertension; 2007 Feb; 49(2):311-6. PubMed ID: 17178978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study.
    Pathansali R; Smith NM; Bath PM
    Platelets; 2001 May; 12(3):144-9. PubMed ID: 11304415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet function and spontaneous thrombolytic activity of patients with cerebral infarction assessed by the global thrombosis test.
    Taomoto K; Ohnishi H; Kuga Y; Nakashima K; Ichioka T; Kodama Y; Kubota H; Tominaga T; Hirose T; Hayashi M; Kinugasa C; Yamashita T; Yamamoto J
    Pathophysiol Haemost Thromb; 2010; 37(1):43-8. PubMed ID: 20516672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet activation and interactions with the microvasculature.
    Body SC
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S13-25. PubMed ID: 8938279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
    Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress and platelets.
    Freedman JE
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):s11-6. PubMed ID: 18174453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S1-5. PubMed ID: 7603071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the new centrally acting antihypertensive agent rilmenidine on endothelial and platelet function in essential hypertension.
    Remková A; Kratochvíl'ová H
    J Hum Hypertens; 2002 Aug; 16(8):549-55. PubMed ID: 12149660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products.
    Willerson JT
    Tex Heart Inst J; 1995; 22(1):13-9. PubMed ID: 7787465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of enalapril maleate on vascular endothelial function and platelet-endothelial interactions in patients with essential hypertension].
    Iakovlev VM; Semenkin AA; Iudin SM; Nazarov AG; Kudriashov IL; Potapov VV; Korennova OIu; Il'iunykh LN
    Ter Arkh; 2000; 72(1):40-4. PubMed ID: 10687205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic function and atrial fibrillation.
    Marín F; Roldán V; Lip GY
    Thromb Res; 2003 Mar; 109(5-6):233-40. PubMed ID: 12818244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial cell control of thrombosis.
    Yau JW; Teoh H; Verma S
    BMC Cardiovasc Disord; 2015 Oct; 15():130. PubMed ID: 26481314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.